Those sanctions were based on drug tests.
This study was designed to evaluate the effects of different formulation variables, i.e. type of non-volatile liquid vehicles and drug concentrations, on drug dissolution rates.
The procedure is based on initial dissolution of lipophilic drug molecules within the hydrophobic cores of the micelles of a bio-compatible block-copolymer by ionic gelation and subsequent formation of a chitosan shell by polymerization around the micellar structures.
Therefore an attempt to establish an in vitro- in vivo correlation/relationship model for this drug was made, based on the dissolution data obtained from this novel unconventional dissolution instrument.
The methods used for studying the release of these drugs are mainly based on standard dissolution tests in which the tablets are immersed in large amounts of release medium to determine their dissolution rates [15 17].
At a higher freezing rate, smaller interstitial spaces containing the freeze-concentrated fraction were formed, resulting in smaller drug crystals (based on dissolution data).
Based on the dissolution data, we conclude that a higher freezing rate and a lower temperature at which the solutes crystallized, resulted in smaller drug crystals.
Lysozyme activities in the serum were measured based on the dissolution ability against Micrococcus lysodeikticus (Sigma) [ 40].
Based on the dissolution profiles, HPMC K100LV 30%, HPMC K4M 20%, PEO N60K20%%, and PEO N60K 30% matrices presented a combination of polymer type, MW, concentration, and complete drug release that could result in a formulation able to resist to the destructive forces within the gastrointestinal tract, providing a superior in vivo performance.
This method of disintegration is based on the dissolution of soluble components followed by the filtration and drying of insoluble components.
